Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma
Open Access
- 3 March 2017
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 15 (1) , 1-6
Abstract
Resectable lung adenocarcinoma is dominated by peripheral distribution, and surgical resection is the main treatment protocol. However, high recurrence rate remains after surgery. Lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation has strong invasion ability, but the effects of this mutation on local invasion in early lung adenocarcinoma have been rarely studied. This study aimed to assess the effects of EGFR mutation on local invasion in resectable lung adenocarcinoma. A retrospective analysis of 103 patients clinically diagnosed with peripheral lung adenocarcinoma was included. They underwent preoperative bronchoscopy, which indicated grades 2 or 3 bronchial involvement (lumen of the lobe or segment). The associations of EGFR mutation with pleural invasion, endobronchial metastasis, and lymph node metastasis were analyzed according to pathologies of pleural invasion and lymph node metastasis, as well as EGFR gene mutation detected by postoperative pathological specimens. Statistical analyses were performed by unpaired Chi-square test using the SPSS16.0 software. In patients with EGFR mutation, pleural invasion, endobronchial metastasis, and lymph node metastasis rates were 62.5, 39.1, and 34.4%, respectively, indicating statistically significant differences (p = 0.003). Meanwhile, the pleural invasion rate in patients with wild-type EGFR was 43.6%, significantly reduced compared with patients with mutated EGFR (62.5%; p = 0.018). In addition, the endobronchial metastasis rate in patients with wild-type EGFR was 17.9%, significantly lower than in patients with EGFR mutation (39.1%; p = 0.005). However, lymph node metastasis rates were similar between EGFR mutated and wild-type patients (34.4 vs 25.6%, respectively, p > 0.05). Early resectable lung adenocarcinoma patients with EGFR mutation showed a higher rate of local invasion compared with those harboring wild-type EGFR. This finding provides a basis for improved therapy. This study was supported by Project of Medical and Health Science Technology in Shandong Province ( 2015WS0376 )Keywords
Funding Information
- Project of Medical and Health Science Technology in Shandong Province (2015WS0376)
This publication has 28 references indexed in Scilit:
- Extended Sleeve Lobectomy: One More Step Toward Avoiding Pneumonectomy in Centrally Located Lung CancerThe Annals of Thoracic Surgery, 2013
- Achados de fibrobroncoscopia em pacientes com diagnóstico de neoplasia pulmonarJornal Brasileiro de Pneumologia, 2012
- An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic settingAnnals of Oncology, 2012
- Diagnosis of Lung CancerJournal of Bronchology & Interventional Pulmonology, 2012
- How many pathological T1N0M0 non-small cell lung cancers can be completely resected in one segment? Special reference to high-resolution computed tomography findingsSurgery Today, 2011
- Bronchial resection margin length and clinical outcome in non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2011
- Microscopic Residual Disease After Resection for Lung Cancer: A Multifaceted but Poor Factor of PrognosisThe Annals of Thoracic Surgery, 2010
- The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2009
- Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins — implications for patient selection for segmentectomy☆European Journal of Cardio-Thoracic Surgery, 2007
- Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2002